Industry Insights: Healthcare 7th August
Industry Insights Healthcare: 07/08/24 In this week’s insight, we will briefly summarise three of the latest developments in the healthcare industry. Wegovy® (semaglutide), the new weight-loss drug, becomes available in AustraliaNovo Nordisk’s Wegovy®, a new semaglutide brand for weight loss, will be available in Australia from August 2024. Wegovy® is approved for chronic weight management […]
Industry Insights: Healthcare 28th June
Industry Insights Healthcare: 28/06/24 Here are three briefly summarised articles to help keep you informed of the latest developments in the industry. Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity Novo Nordisk has announced a $4.1 billion investment to construct a second fill and finishing manufacturing facility in Clayton, North Carolina. […]
Industry Insights: Healthcare 9th June
Industry Insights Healthcare: 09/06/24 Here are three briefly summarised articles to help keep you informed of the latest developments in the industry. Moderna receives U.S. FDA Approval for RSV vaccine mRSEVIA Moderna has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA to protect adults aged 60 years and older from respiratory […]
Industry Insight: Healthcare 17 May
This week’s Healthcare Industry Insights focuses on innovations in breast cancer vaccines, key results from the recently published Global Burden of Disease 2021 study, and the results of a study looking at how proteins in the blood could be an early cancer warning. The race for a breast cancer vaccineThere have been noticeable developments […]
Industry Insight: Healthcare 8 April
This week’s Healthcare Industry Insights focuses on changes to China’s medical-device industry, users’ experiences with health-related content on Youtube, and FDA approval for a new antibiotic. China’s medical device industry gets a makeover This Nature article (part of Nature Spotlight: Medical devices in China) highlights the intensified push by the Chinese Government to produce and […]
Industry Insight: Healthcare 15 March
Industry Insight: Healthcare 15 March This week our Healthcare Industry Insights focuses on a new approval indication for Novo Nordisk’s Wegovy, a pending decision on donanemab for Alzheimers, and potential withdrawal of the ALS drug, Relyvrio. FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight Semaglutide […]
Industry Insight: Healthcare 22 February
We have summarised three articles to help keep you informed of the latest developments in the industry. This week, our Healthcare Industry Insight looks at positive pre-clinical results for THIO, an investigational telomere targeting agent, in small-cell lung cancer. We also take a look at new FDA drug approvals for advanced melanoma and food allergens. […]
Industry Insights: Healthcare 31 January
We have summarised three articles to help keep you informed of the latest developments in the industry. This week, our Industry Insights post looks at three important updates from the U.S. Food and Drug Administration (FDA). The FDA has investigated the risk of T-cell malignancy following BCMA-directed or CD19-directed autologous chimeric antigen receptor (CAR) T-cell […]
Industry Insights: Healthcare 18 December
We have summarised three articles to help keep you informed of the latest developments in the industry. This week our Industry Insights focus on a major breakthrough for severe asthma treatment, three-year follow-up data from the phase 2b randomised KEYNOTE-942-/mRNA-4157-P201 study, and a new clinical trial looking at stem cell-based treatment for blood glucose control […]
Industry Insights: Healthcare 28 November
We have summarised three articles to help keep you informed of the latest developments in the industry. This week our Industry Insights look at the U.S Food and Drug Administration (FDA) approval of Zepbound (tirzepatide) for chronic weight management, a World Health Organisation (WHO) statement on reported clusters of respiratory illness in children in northern […]
Industry Insights: Healthcare 6 November
This week our Industry Insights: Healthcare looks at the potential for Food and Drug Administration (FDA) approval of CRISPR for sickle cell anaemia, new lung cancer screening guidelines by the American Cancer Society, and FDA approval for Phathom’s Voquezna. A panel of external advisors to the FDA has found the safety data for Exagamglogene Autotemcel […]
Industry Insights: Healthcare 16 October
Industry Insights: Healthcare
